Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cosimo Durante

Showing results (21-30 of 175) with videos related to

Pageof 18
Sort By:
Endocrine|April 16, 2013
Vandetanib: opening a new treatment practice in advanced medullary thyroid carcinomaCosimo Durante, Alessandra Paciaroni, Katia Plasmati, et al.
The Journal of Clinical Endocrinology and Metabolism|June 4, 2020
Contemporary Thyroid Nodule Evaluation and ManagementGiorgio Grani, Marialuisa Sponziello, Valeria Pecce, et al.
Recenti Progressi in Medicina|January 27, 2007
[Cardiovascular disease and metabolic syndrome]Marianna Maranghi, Paola Coletta, Cosimo Durante, et al.
Nature Clinical Practice. Endocrinology & Metabolism|December 17, 2008
Determination of calcitonin levels in C-cell disease: clinical interest and potential pitfallsGiuseppe Costante, Cosimo Durante, Zélia Francis, et al.
Clinical Endocrinology|October 4, 2019
Comment on: BRAF mutation analysis by ARMS-PCR refines thyroid nodule managementAntonella Verrienti, Marialuisa Sponziello, Cosimo Durante, et al.
Endocrine|October 17, 2019
Thyroid hormone therapy in differentiated thyroid cancerGiorgio Grani, Valeria Ramundo, Antonella Verrienti, et al.
Trends in Endocrinology and Metabolism: TEM|March 14, 2008
Clinical implications of BRAF mutation in thyroid carcinomaEfisio Puxeddu, Cosimo Durante, Nicola Avenia, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|September 6, 2024
Multiparametric ultrasound evaluation of thyroid nodulesVito Cantisani, Jörg Bojunga, Cosimo Durante, et al.
Endocrine|August 20, 2022
Operation rate and cancer prevalence among thyroid nodules with FNAC report of suspicious for malignancy (TIR4) or malignant (TIR5) according to Italian classification system: a systematic review and meta-analysisPierpaolo Trimboli, Giulia Ferrarazzo, Arnoldo Piccardo, et al.
The Lancet. Diabetes & Endocrinology|October 9, 2019
Screening for differentiated thyroid cancer in selected populationsLivia Lamartina, Giorgio Grani, Cosimo Durante, et al.
Pageof 18

Showing results (21-30 of 175) with videos related to

Sort By:
Pageof 18
Endocrine|April 16, 2013
Vandetanib: opening a new treatment practice in advanced medullary thyroid carcinomaCosimo Durante, Alessandra Paciaroni, Katia Plasmati, et al.
The Journal of Clinical Endocrinology and Metabolism|June 4, 2020
Contemporary Thyroid Nodule Evaluation and ManagementGiorgio Grani, Marialuisa Sponziello, Valeria Pecce, et al.
Recenti Progressi in Medicina|January 27, 2007
[Cardiovascular disease and metabolic syndrome]Marianna Maranghi, Paola Coletta, Cosimo Durante, et al.
Nature Clinical Practice. Endocrinology & Metabolism|December 17, 2008
Determination of calcitonin levels in C-cell disease: clinical interest and potential pitfallsGiuseppe Costante, Cosimo Durante, Zélia Francis, et al.
Clinical Endocrinology|October 4, 2019
Comment on: BRAF mutation analysis by ARMS-PCR refines thyroid nodule managementAntonella Verrienti, Marialuisa Sponziello, Cosimo Durante, et al.
Endocrine|October 17, 2019
Thyroid hormone therapy in differentiated thyroid cancerGiorgio Grani, Valeria Ramundo, Antonella Verrienti, et al.
Trends in Endocrinology and Metabolism: TEM|March 14, 2008
Clinical implications of BRAF mutation in thyroid carcinomaEfisio Puxeddu, Cosimo Durante, Nicola Avenia, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|September 6, 2024
Multiparametric ultrasound evaluation of thyroid nodulesVito Cantisani, Jörg Bojunga, Cosimo Durante, et al.
Endocrine|August 20, 2022
Operation rate and cancer prevalence among thyroid nodules with FNAC report of suspicious for malignancy (TIR4) or malignant (TIR5) according to Italian classification system: a systematic review and meta-analysisPierpaolo Trimboli, Giulia Ferrarazzo, Arnoldo Piccardo, et al.
The Lancet. Diabetes & Endocrinology|October 9, 2019
Screening for differentiated thyroid cancer in selected populationsLivia Lamartina, Giorgio Grani, Cosimo Durante, et al.
Pageof 18